Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy.
Charcot-Marie-Tooth Disease: An Overview of Genotypes, Phenotypes, and Clinical Management Strategies.
Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis.
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK.
MObility ImproVEment with spasticity in multiple sclerosis in Europe: the MOVE 1 EU study.
Patient taking Novartis MS pill developed rare disease
Local delivery of FTY720 in PCL membrane improves SCI functional recovery by reducing reactive astrogliosis.
Aquaporin-4 antibody neuromyelitis optica following anti-NMDA receptor encephalitis.
CCL2 induction by 1,25(OH)2D3 in dendritic cells from healthy donors and multiple sclerosis patients.
Multiple sclerosis: Neuroimaging provides insights into cognitive dysfunction in MS.
Epigenetics and the Modulation of Neuroinflammation.
Fall Incidence as the Primary Outcome in Multiple Sclerosis Falls-Prevention Trials: Recommendation from the International MS Falls Prevention Research Network.
The role of complement in inflammatory diseases from behind the scenes into the spotlight.
Quality of life and patient preferences: identification of subgroups of multiple sclerosis patients.
Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis (MS-STAT)
Therapeutic effects of anti-Delta1 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patients.
Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing- remitting multiple sclerosis.
The Olig family affects central nervous system development and disease.
The importance of CCR4 and CCR6 in experimental autoimmune encephalomyelitis.
Moving to Fingolimod From Natalizumab in Multiple Sclerosis: The ENIGM Is Not Solved.
Several food items and multiple sclerosis: A case-control study in Ahvaz (Iran).
A rare case of hyponatremia from a hypothalamic lesion in a patient with multiple sclerosis.
Health-related quality of life in multiple sclerosis patients with bladder, bowel and sexual dysfunction.
Transverse myelitis due to Staphylococcus aureus may occur without contiguous spread.
Pages
« first
‹ previous
…
386
387
388
389
390
391
392
393
394
…
next ›
last »